Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK14 | Q16539 | 12/20 | 0.61 |
| ▸ | MAPK13 | O15264 | 7/20 | 0.61 |
| ▸ | MAPK9 | P45984 | 7/20 | 0.61 |
| ▸ | MAPK12 | P53778 | 7/20 | 0.61 |
| ▸ | MAPK11 | Q15759 | 7/20 | 0.61 |
| ▸ | RAF1 | P04049 | 5/20 | 0.61 |
| ▸ | CSNK1D | P48730 | 4/20 | 0.59 |
| ▸ | JAK3 | P52333 | 1/20 | 0.59 |
| ▸ | CSNK1A1 | P48729 | 2/20 | 0.49 |
| ▸ | RPS6KA3 | P51812 | 2/20 | 0.49 |
| ▸ | CCNA2 | P20248 | 1/20 | 0.43 |
| ▸ | CDK2 | P24941 | 1/20 | 0.43 |
| ▸ | CSNK1E | P49674 | 1/20 | 0.43 |
| ▸ | CDK5 | Q00535 | 1/20 | 0.43 |
| ▸ | CDK5R1 | Q15078 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6950701 | 0.89 | MAPK14 (0.60) | MAPK14MAPK13MAPK9MAPK12MAPK11 | |
| SCHEMBL4585060 | 0.89 | MAPK14 (0.60) | MAPK14MAPK13MAPK9MAPK12MAPK11 | |
| SCHEMBL4583956 | 0.88 | MAPK14 (0.57) | MAPK14MAPK13MAPK9MAPK12MAPK11 | |
| SCHEMBL4585443 | 0.88 | MAPK14 (0.57) | MAPK14MAPK13MAPK9MAPK12MAPK11 | |
| SCHEMBL4583940 | 0.84 | MAPK14 (0.65) | MAPK14MAPK13MAPK9MAPK12MAPK11 | |
| SCHEMBL1387444 | 0.84 | MAPK14 (0.67) | MAPK14MAPK13MAPK9MAPK12MAPK11 | |
| SCHEMBL4585684 | 0.83 | MAPK14 (0.61) | MAPK14MAPK13MAPK9MAPK12MAPK11 | |
| SCHEMBL7988334 | 0.83 | CSNK1A1 (0.69) | MAPK14MAPK13MAPK9MAPK12MAPK11 | |
| Hydrochloric Acid SCHEMBL16415792 | 0.83 | MAPK14 (0.66) | MAPK14MAPK13MAPK9MAPK12MAPK11 | |
| SCHEMBL4583070 | 0.82 | MAPK14 (0.60) | MAPK14MAPK13MAPK9MAPK12MAPK11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1539121-A4 | METHODS OF PROMOTING OSTEOGENESIS | SCIOS INC (US) | 2008-08-13 | — | — | EP | disclosed |
| EP-1545535-A4 | TREATMENT OF PAIN BY INHIBITION OF P38 MAP KINASE | SCIOS INC (US) | 2008-06-04 | — | — | EP | disclosed |
| EP-1583535-A4 | METHODS FOR TREATING DIABETES | SCIOS INC (US) | 2008-03-19 | — | — | EP | disclosed |
| EP-1583535-A2 | METHODS FOR TREATING DIABETES | SCIOS INC. (US) | 2005-10-12 | — | — | EP | disclosed |
| EP-1545535-A2 | TREATMENT OF PAIN BY INHIBITION OF P38 MAP KINASE | SCIOS INC. (US) | 2005-06-29 | — | — | EP | disclosed |
| EP-1539121-A2 | METHODS OF PROMOTING OSTEOGENESIS | SCIOS INC. (US) | 2005-06-15 | — | — | EP | disclosed |
| WO-2005032551-A1 | TREATMENT OF CARDIOVASCULAR DISEASE WITH INHIBITORS OF p38 KINASE | SCIOS INC. (US) | 2005-04-14 | — | — | WO | disclosed |
| WO-2004019873-A9 | METHODS OF PROMOTING OSTEOGENESIS | SCIOS INC (US) | 2004-06-24 | — | — | WO | disclosed |
| WO-2004053107-A2 | METHODS FOR TREATING DIABETES | SCIOS INC. (US) | 2004-06-24 | — | — | WO | disclosed |
| WO-2004024083-A2 | METHODS OF BONE HEALING | UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY (US) | 2004-03-25 | — | — | WO | disclosed |
| WO-2004021988-A2 | TREATMENT OF PAIN BY INHIBITION OF P38 MAP KINASE | SCIOS INC. (US) | 2004-03-18 | — | — | WO | disclosed |
| WO-2004019873-A2 | METHODS OF PROMOTING OSTEOGENESIS | SCIOS INC. (US) | 2004-03-11 | — | — | WO | disclosed |
| EP-0889888-A4 | NOVEL TREATMENT FOR CNS INJURIES | SMITHKLINE BEECHAM CORP (US) | 2003-01-08 | — | — | EP | disclosed |
| EP-0889888-A1 | NOVEL TREATMENT FOR CNS INJURIES | SMITHKLINE BEECHAM CORPORATION (US) | 1999-01-13 | — | — | EP | disclosed |
| WO-1997035856-A1 | NOVEL TREATMENT FOR CNS INJURIES | SMITHKLINE BEECHAM CORPORATION (US) | 1997-10-02 | — | — | WO | disclosed |